Topical gel for preventing stretch marks now available; New market forecast published;

> Switzerland's Stratpharma AG has developed topical gel for the prevention and treatment of stretch marks, which occur during pregnancy. The CE marked medical device is available for sale in Europe. Release

> Drug Delivery Technologies has released a market forecast for 2014 to 2024. It includes the prospects of various administration routes, including nasal, ocular and transdemeral. Also included are the prospects of various biologics such as monoclonal antibodies and insulins. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.